Relation between Selected Sleep Parameters, Depression, Anti-Tumor Necrosis Factor Therapy, and the Brain-Derived Neurotrophic Factor Pathway in Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) patients often have sleep and mood disorders. Brain-derived neurotrophic factor (BDNF) and proBDNF were shown to modulate interactions between the central nervous system and the gastrointestinal tract, possibly contributing to psychological issues. Anti-tumor necrosi...

Full description

Bibliographic Details
Main Authors: Marcin Sochal, Marta Ditmer, Agata Binienda, Agata Gabryelska, Piotr Białasiewicz, Renata Talar-Wojnarowska, Jakub Fichna, Ewa Małecka-Wojciesko
Format: Article
Language:English
Published: MDPI AG 2023-03-01
Series:Metabolites
Subjects:
Online Access:https://www.mdpi.com/2218-1989/13/3/450
_version_ 1797610181547261952
author Marcin Sochal
Marta Ditmer
Agata Binienda
Agata Gabryelska
Piotr Białasiewicz
Renata Talar-Wojnarowska
Jakub Fichna
Ewa Małecka-Wojciesko
author_facet Marcin Sochal
Marta Ditmer
Agata Binienda
Agata Gabryelska
Piotr Białasiewicz
Renata Talar-Wojnarowska
Jakub Fichna
Ewa Małecka-Wojciesko
author_sort Marcin Sochal
collection DOAJ
description Inflammatory bowel disease (IBD) patients often have sleep and mood disorders. Brain-derived neurotrophic factor (BDNF) and proBDNF were shown to modulate interactions between the central nervous system and the gastrointestinal tract, possibly contributing to psychological issues. Anti-tumor necrosis factor (TNF) therapy in IBD can alter BDNF expression and further affect the brain–gut axis. Eighty IBD patients and 44 healthy controls (HCs) were enrolled and divided into subsets based on disease activity and condition (ulcerative colitis (UC)/Crohn’s disease (CD)). Questionnaires evaluating sleep parameters and depression as well as venous blood were collected. The IBD group had a lower expression of BDNF mRNA, but higher proBDNF and BDNF protein concentration than HCs. The UC group had a higher BDNF protein concentration than the CD. BDNF protein was positively correlated to sleep efficiency in the IBD group. Depression severity was associated positively with BDNF mRNA and negatively with BDNF protein in the remission group. Anti-TNF therapy enhanced BDNF mRNA expression. The BDNF pathway might be disturbed in IBD, linking it to sleep disorders and depression. Systemic inflammation could be the main cause of this disruption. BDNF mRNA is a more reliable parameter than protein due to numerous post-translational modifications.
first_indexed 2024-03-11T06:11:55Z
format Article
id doaj.art-fd2aa86830db412aa15f32bb2134e152
institution Directory Open Access Journal
issn 2218-1989
language English
last_indexed 2024-03-11T06:11:55Z
publishDate 2023-03-01
publisher MDPI AG
record_format Article
series Metabolites
spelling doaj.art-fd2aa86830db412aa15f32bb2134e1522023-11-17T12:37:39ZengMDPI AGMetabolites2218-19892023-03-0113345010.3390/metabo13030450Relation between Selected Sleep Parameters, Depression, Anti-Tumor Necrosis Factor Therapy, and the Brain-Derived Neurotrophic Factor Pathway in Inflammatory Bowel DiseaseMarcin Sochal0Marta Ditmer1Agata Binienda2Agata Gabryelska3Piotr Białasiewicz4Renata Talar-Wojnarowska5Jakub Fichna6Ewa Małecka-Wojciesko7Department of Sleep Medicine and Metabolic Disorders, Medical University of Lodz, 90-419 Lodz, PolandDepartment of Sleep Medicine and Metabolic Disorders, Medical University of Lodz, 90-419 Lodz, PolandDepartment of Biochemistry, Medical University of Lodz, 90-419 Lodz, PolandDepartment of Sleep Medicine and Metabolic Disorders, Medical University of Lodz, 90-419 Lodz, PolandDepartment of Sleep Medicine and Metabolic Disorders, Medical University of Lodz, 90-419 Lodz, PolandDepartment of Digestive Tract Diseases, Medical University of Lodz, 92-215 Lodz, PolandDepartment of Biochemistry, Medical University of Lodz, 90-419 Lodz, PolandDepartment of Digestive Tract Diseases, Medical University of Lodz, 92-215 Lodz, PolandInflammatory bowel disease (IBD) patients often have sleep and mood disorders. Brain-derived neurotrophic factor (BDNF) and proBDNF were shown to modulate interactions between the central nervous system and the gastrointestinal tract, possibly contributing to psychological issues. Anti-tumor necrosis factor (TNF) therapy in IBD can alter BDNF expression and further affect the brain–gut axis. Eighty IBD patients and 44 healthy controls (HCs) were enrolled and divided into subsets based on disease activity and condition (ulcerative colitis (UC)/Crohn’s disease (CD)). Questionnaires evaluating sleep parameters and depression as well as venous blood were collected. The IBD group had a lower expression of BDNF mRNA, but higher proBDNF and BDNF protein concentration than HCs. The UC group had a higher BDNF protein concentration than the CD. BDNF protein was positively correlated to sleep efficiency in the IBD group. Depression severity was associated positively with BDNF mRNA and negatively with BDNF protein in the remission group. Anti-TNF therapy enhanced BDNF mRNA expression. The BDNF pathway might be disturbed in IBD, linking it to sleep disorders and depression. Systemic inflammation could be the main cause of this disruption. BDNF mRNA is a more reliable parameter than protein due to numerous post-translational modifications.https://www.mdpi.com/2218-1989/13/3/450IBDBDNFanti-TNF therapysleepdepression
spellingShingle Marcin Sochal
Marta Ditmer
Agata Binienda
Agata Gabryelska
Piotr Białasiewicz
Renata Talar-Wojnarowska
Jakub Fichna
Ewa Małecka-Wojciesko
Relation between Selected Sleep Parameters, Depression, Anti-Tumor Necrosis Factor Therapy, and the Brain-Derived Neurotrophic Factor Pathway in Inflammatory Bowel Disease
Metabolites
IBD
BDNF
anti-TNF therapy
sleep
depression
title Relation between Selected Sleep Parameters, Depression, Anti-Tumor Necrosis Factor Therapy, and the Brain-Derived Neurotrophic Factor Pathway in Inflammatory Bowel Disease
title_full Relation between Selected Sleep Parameters, Depression, Anti-Tumor Necrosis Factor Therapy, and the Brain-Derived Neurotrophic Factor Pathway in Inflammatory Bowel Disease
title_fullStr Relation between Selected Sleep Parameters, Depression, Anti-Tumor Necrosis Factor Therapy, and the Brain-Derived Neurotrophic Factor Pathway in Inflammatory Bowel Disease
title_full_unstemmed Relation between Selected Sleep Parameters, Depression, Anti-Tumor Necrosis Factor Therapy, and the Brain-Derived Neurotrophic Factor Pathway in Inflammatory Bowel Disease
title_short Relation between Selected Sleep Parameters, Depression, Anti-Tumor Necrosis Factor Therapy, and the Brain-Derived Neurotrophic Factor Pathway in Inflammatory Bowel Disease
title_sort relation between selected sleep parameters depression anti tumor necrosis factor therapy and the brain derived neurotrophic factor pathway in inflammatory bowel disease
topic IBD
BDNF
anti-TNF therapy
sleep
depression
url https://www.mdpi.com/2218-1989/13/3/450
work_keys_str_mv AT marcinsochal relationbetweenselectedsleepparametersdepressionantitumornecrosisfactortherapyandthebrainderivedneurotrophicfactorpathwayininflammatoryboweldisease
AT martaditmer relationbetweenselectedsleepparametersdepressionantitumornecrosisfactortherapyandthebrainderivedneurotrophicfactorpathwayininflammatoryboweldisease
AT agatabinienda relationbetweenselectedsleepparametersdepressionantitumornecrosisfactortherapyandthebrainderivedneurotrophicfactorpathwayininflammatoryboweldisease
AT agatagabryelska relationbetweenselectedsleepparametersdepressionantitumornecrosisfactortherapyandthebrainderivedneurotrophicfactorpathwayininflammatoryboweldisease
AT piotrbiałasiewicz relationbetweenselectedsleepparametersdepressionantitumornecrosisfactortherapyandthebrainderivedneurotrophicfactorpathwayininflammatoryboweldisease
AT renatatalarwojnarowska relationbetweenselectedsleepparametersdepressionantitumornecrosisfactortherapyandthebrainderivedneurotrophicfactorpathwayininflammatoryboweldisease
AT jakubfichna relationbetweenselectedsleepparametersdepressionantitumornecrosisfactortherapyandthebrainderivedneurotrophicfactorpathwayininflammatoryboweldisease
AT ewamałeckawojciesko relationbetweenselectedsleepparametersdepressionantitumornecrosisfactortherapyandthebrainderivedneurotrophicfactorpathwayininflammatoryboweldisease